248 related articles for article (PubMed ID: 30257595)
21. MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity
Sargiacomo C; Stonehouse S; Moftakhar Z; Sotgia F; Lisanti MP
Front Oncol; 2021; 11():678343. PubMed ID: 34395247
[TBL] [Abstract][Full Text] [Related]
22. Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes.
Ma X; Zhou J; Zhang CX; Li XY; Li N; Ju RJ; Shi JF; Sun MG; Zhao WY; Mu LM; Yan Y; Lu WL
Biomaterials; 2013 Jun; 34(18):4452-65. PubMed ID: 23518403
[TBL] [Abstract][Full Text] [Related]
23. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
[TBL] [Abstract][Full Text] [Related]
24. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells.
Lamb R; Ozsvari B; Bonuccelli G; Smith DL; Pestell RG; Martinez-Outschoorn UE; Clarke RB; Sotgia F; Lisanti MP
Oncotarget; 2015 Sep; 6(26):21892-905. PubMed ID: 26323205
[TBL] [Abstract][Full Text] [Related]
25. Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito-stemness and ribo-stemness features.
Peiris-Pagès M; Ozsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Jul; 11(14):4801-4835. PubMed ID: 31311889
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial biology in cancer stem cells.
Loureiro R; Mesquita KA; Magalhães-Novais S; Oliveira PJ; Vega-Naredo I
Semin Cancer Biol; 2017 Dec; 47():18-28. PubMed ID: 28673608
[TBL] [Abstract][Full Text] [Related]
27. Metformin and prostate cancer stem cells: a novel therapeutic target.
Mayer MJ; Klotz LH; Venkateswaran V
Prostate Cancer Prostatic Dis; 2015 Dec; 18(4):303-9. PubMed ID: 26215782
[TBL] [Abstract][Full Text] [Related]
28. Repurposing atovaquone: targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells.
Fiorillo M; Lamb R; Tanowitz HB; Mutti L; Krstic-Demonacos M; Cappello AR; Martinez-Outschoorn UE; Sotgia F; Lisanti MP
Oncotarget; 2016 Jun; 7(23):34084-99. PubMed ID: 27136895
[TBL] [Abstract][Full Text] [Related]
29. Deferiprone (DFP) Targets Cancer Stem Cell (CSC) Propagation by Inhibiting Mitochondrial Metabolism and Inducing ROS Production.
Fiorillo M; Tóth F; Brindisi M; Sotgia F; Lisanti MP
Cells; 2020 Jun; 9(6):. PubMed ID: 32585919
[TBL] [Abstract][Full Text] [Related]
30. Mitoriboscins: Mitochondrial-based therapeutics targeting cancer stem cells (CSCs), bacteria and pathogenic yeast.
Ozsvari B; Fiorillo M; Bonuccelli G; Cappello AR; Frattaruolo L; Sotgia F; Trowbridge R; Foster R; Lisanti MP
Oncotarget; 2017 Sep; 8(40):67457-67472. PubMed ID: 28978045
[TBL] [Abstract][Full Text] [Related]
31. Dodecyl-TPP Targets Mitochondria and Potently Eradicates Cancer Stem Cells (CSCs): Synergy With FDA-Approved Drugs and Natural Compounds (Vitamin C and Berberine).
De Francesco EM; Ózsvári B; Sotgia F; Lisanti MP
Front Oncol; 2019; 9():615. PubMed ID: 31440463
[TBL] [Abstract][Full Text] [Related]
32. Mitochondria in cancer stem cells: a target for therapy.
Loureiro R; Mesquita KA; Oliveira PJ; Vega-Naredo I
Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):102-14. PubMed ID: 23360288
[TBL] [Abstract][Full Text] [Related]
33. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
34. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
35. Combining PEGylated mito-atovaquone with MCT and Krebs cycle redox inhibitors as a potential strategy to abrogate tumor cell proliferation.
Cheng G; Hardy M; You M; Kalyanaraman B
Sci Rep; 2022 Mar; 12(1):5143. PubMed ID: 35332210
[TBL] [Abstract][Full Text] [Related]
36. An insight into the associations between microRNA expression and mitochondrial functions in cancer cell and cancer stem cell.
Tan WL; Subha ST; Mohtarrudin N; Cheah YK
Mol Biol Rep; 2023 Jun; 50(6):5395-5405. PubMed ID: 37074612
[TBL] [Abstract][Full Text] [Related]
37. Mitochondria-targeted vitamin E analogs inhibit breast cancer cell energy metabolism and promote cell death.
Cheng G; Zielonka J; McAllister DM; Mackinnon AC; Joseph J; Dwinell MB; Kalyanaraman B
BMC Cancer; 2013 Jun; 13():285. PubMed ID: 23764021
[TBL] [Abstract][Full Text] [Related]
38. Cancer Stem Cells in Small Cell Lung Cancer Cell Line H446: Higher Dependency on Oxidative Phosphorylation and Mitochondrial Substrate-Level Phosphorylation than Non-Stem Cancer Cells.
Gao C; Shen Y; Jin F; Miao Y; Qiu X
PLoS One; 2016; 11(5):e0154576. PubMed ID: 27167619
[TBL] [Abstract][Full Text] [Related]
39. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach.
Malhi S; Gu X
Expert Opin Drug Deliv; 2015 Jul; 12(7):1177-201. PubMed ID: 25601619
[TBL] [Abstract][Full Text] [Related]
40. Combination therapy targeting both cancer stem-like cells and bulk tumor cells for improved efficacy of breast cancer treatment.
Wang T; Narayanaswamy R; Ren H; Torchilin VP
Cancer Biol Ther; 2016 Jun; 17(6):698-707. PubMed ID: 27259361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
